February 17, 2015 Vaxin enters definitive agreement to acquire Immune Targeting Systems (ITS); Secures $16m in new financing
February 17, 2015 Orexo broadens ZUBSOLV® product range and announces newly listed granted US patent.
February 10, 2015 Ultragenyx Announces Positive 36-Week Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7
February 09, 2015 CERENIS THERAPEUTICS announces the appointment of a new Chief Medical Officer and new Board Members